A detailed history of National Asset Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, National Asset Management, Inc. holds 18,327 shares of AZN stock, worth $1.22 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
18,327
Previous 23,504 22.03%
Holding current value
$1.22 Million
Previous $1.59 Million 10.24%
% of portfolio
0.04%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 19, 2024

SELL
$66.81 - $80.83 $345,875 - $418,456
-5,177 Reduced 22.03%
18,327 $1.43 Million
Q1 2024

May 16, 2024

BUY
$61.03 - $69.57 $379,850 - $433,003
6,224 Added 36.02%
23,504 $1.59 Million
Q4 2023

Mar 15, 2024

SELL
$61.89 - $69.28 $385,203 - $431,198
-6,224 Reduced 26.48%
17,280 $1.16 Million
Q3 2023

Dec 01, 2023

SELL
$64.85 - $71.7 $1.21 Million - $1.34 Million
-18,694 Reduced 44.3%
23,504 $1.59 Million
Q2 2023

Jul 27, 2023

BUY
$69.91 - $75.81 $1.61 Million - $1.75 Million
23,037 Added 120.23%
42,198 $3.02 Million
Q1 2023

May 17, 2023

BUY
$63.15 - $71.6 $285,311 - $323,488
4,518 Added 30.85%
19,161 $1.33 Million
Q4 2022

Feb 21, 2023

SELL
$54.21 - $70.44 $106,034 - $137,780
-1,956 Reduced 11.78%
14,643 $992,000
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $117,810 - $301,636
-2,222 Reduced 11.81%
16,599 $911,000
Q2 2022

Aug 12, 2022

SELL
$59.26 - $71.14 $201,246 - $241,591
-3,396 Reduced 15.29%
18,821 $1.25 Million
Q1 2022

May 02, 2022

BUY
$55.72 - $67.12 $359,784 - $433,393
6,457 Added 40.97%
22,217 $1.48 Million
Q4 2021

Jan 28, 2022

SELL
$54.02 - $63.83 $190,474 - $225,064
-3,526 Reduced 18.28%
15,760 $919,000
Q3 2021

Nov 16, 2021

BUY
$55.56 - $60.79 $451,091 - $493,554
8,119 Added 72.71%
19,286 $1.16 Million
Q2 2021

Aug 10, 2021

SELL
$48.42 - $60.18 $12,443 - $15,466
-257 Reduced 2.25%
11,167 $669,000
Q1 2021

May 13, 2021

BUY
$47.16 - $54.44 $245,703 - $283,632
5,210 Added 83.84%
11,424 $568,000
Q4 2020

Feb 04, 2021

SELL
$48.52 - $58.02 $45,608 - $54,538
-940 Reduced 13.14%
6,214 $311,000
Q3 2020

Nov 09, 2020

BUY
$53.07 - $61.1 $1,432 - $1,649
27 Added 0.38%
7,154 $393,000
Q2 2020

Jul 31, 2020

BUY
$43.1 - $55.31 $89,604 - $114,989
2,079 Added 41.18%
7,127 $377,000
Q1 2020

May 06, 2020

SELL
$37.79 - $51.33 $3,930 - $5,338
-104 Reduced 2.02%
5,048 $226,000
Q4 2019

Feb 10, 2020

SELL
$42.46 - $50.46 $1,061 - $1,261
-25 Reduced 0.48%
5,152 $257,000
Q3 2019

Nov 12, 2019

BUY
$40.12 - $45.47 $207,701 - $235,398
5,177 New
5,177 $231,000
Q2 2019

Aug 05, 2019

SELL
$37.28 - $41.68 $192,998 - $215,777
-5,177 Closed
0 $0
Q1 2019

May 08, 2019

SELL
$35.49 - $43.02 $21,577 - $26,156
-608 Reduced 10.51%
5,177 $210,000
Q4 2018

Feb 08, 2019

SELL
$36.86 - $41.49 $50,313 - $56,633
-1,365 Reduced 19.09%
5,785 $220,000
Q3 2018

Nov 08, 2018

SELL
$34.76 - $39.72 $16,789 - $19,184
-483 Reduced 6.33%
7,150 $283,000
Q2 2018

Oct 05, 2018

BUY
$34.55 - $37.05 $24,530 - $26,305
710 Added 10.26%
7,633 $268,000
Q1 2018

May 15, 2018

SELL
$32.97 - $36.63 $201,347 - $223,699
-6,107 Reduced 46.87%
6,923 $243,000
Q4 2017

Feb 15, 2018

BUY
$32.09 - $34.78 $52,884 - $57,317
1,648 Added 14.48%
13,030 $453,000
Q3 2017

Nov 13, 2017

BUY
$28.96 - $34.0 $329,622 - $386,988
11,382
11,382 $386,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.